PNW
53
-3
INTC
43
6
SE
49
2
AVB
34
-3
LUV
68
2
CMI
71
2
RIG
40
2
EW
58
5
LYB
22
2
VFC
70
2
BIIB
50
4
CL
58
2
DGX
35
2
TGNA
53
-3
EXPD
51
16
DTE
38
-4
STT
62
3
TRIP
49
2
ED
37
-6
MTB
73
4
PNW
53
-3
INTC
43
6
SE
49
2
AVB
34
-3
LUV
68
2
CMI
71
2
RIG
40
2
EW
58
5
LYB
22
2
VFC
70
2
BIIB
50
4
CL
58
2
DGX
35
2
TGNA
53
-3
EXPD
51
16
DTE
38
-4
STT
62
3
TRIP
49
2
ED
37
-6
MTB
73
4
Financhill
Back

Medexus Pharmaceuticals, Inc. 10K Form

Buy
54

MDP.TO
Medexus Pharmaceuticals, Inc.

Last Price:
$2.74
Seasonality Move:
-5.78%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MDP.TO News And Ratings

See the #1 stock for the next 7 days that we like better than MDP.TO

MDP.TO Financial Statistics

Sales & Book Value

Annual Sales: $150.7M
Cash Flow: $4M
Price / Cash Flow: 4.29
Annual Sales: $2.25
Price / Book: 1.18

Profitability

EPS (TTM): 0.02150
Net Income (TTM): $511.8K
Gross Margin: $77.1M
Return on Equity: 0.82%
Return on Assets: 0.24%

Medexus Pharmaceuticals, Inc. Earnings Forecast

Key Medexus Pharmaceuticals, Inc. Financial Ratios

  • The Gross Profit Margin over the past 15 years for MDP.TO is 51.17%.
  • The Selling, General & Administrative Expenses for MDP.TO have been equal to 12.90% of Gross Profit Margin.
  • The Research & Development expenses have been 1.13% of Revenue.
  • The Interest Expense is 254.21% of Operating Income.
  • The Net Earning history of MDP.TO is 2.07% of Total Revenues.
  • Per Share Earnings over the last 15 years have been positive in 9 years.

Medexus Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: TSX
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: MDP.TO
Website: medexusinc.com

Debt

Debt-to-Equity Ratio: 0.4
Current Ratio: 0.83
Quick Ratio: 0.29

Price-to-Earnings

Trailing P/E Ratio: 22.56
Forward P/E Ratio: 4.94

MDP.TO Technical Analysis vs Fundamental Analysis

Buy
54
Medexus Pharmaceuticals, Inc. (MDP.TO) is a Buy

Is Medexus Pharmaceuticals, Inc. a Buy or a Sell?